Imagine being forced to suffer through multiple painful infections before getting access to a life-changing medical device. That’s the harsh reality thousands of Medicare beneficiaries with spinal cord injuries (SCI) have faced for decades. But thanks to a groundbreaking policy shift championed by Hollister Incorporated, this is finally changing. In a move that’s as bold as it is compassionate, Hollister has successfully pushed for expanded access to closed system intermittent catheters—a game-changer in preventing urinary tract infections (UTIs) and improving quality of life for SCI patients. But here’s where it gets controversial: Why did it take so long for such a critical change to happen? And what does this mean for the future of healthcare equity?**
Hollister Incorporated, a global healthcare leader, has just scored a major victory for patient advocacy. After years of relentless effort, the company has convinced the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) to update their coverage criteria, ensuring that SCI patients no longer have to endure repeated UTIs before qualifying for these essential devices. This shift isn’t just about policy—it’s about dignity, prevention, and empowering patients to live healthier, more independent lives.
A Milestone in Healthcare Equity and Patient Empowerment
For over fifty years, restrictive Medicare policies forced SCI patients to suffer through multiple UTIs before they could access closed system intermittent catheters. These devices, specifically designed to reduce infection risk, were out of reach for many, leaving them vulnerable to recurring health issues. Hollister’s advocacy didn’t just challenge this barrier—it dismantled it. By prioritizing prevention over reaction, the company has set a new standard for patient care.
“This isn’t just a policy win—it’s a leap forward in our mission to make life more rewarding and dignified for those who rely on our products,” said Abinash Nayak, President and CEO of Hollister. “It’s a testament to our commitment to making a real difference in the lives of our customers.”
Relentless Advocacy Yields Results
Three years ago, under the leadership of Casey Haan, Senior Director of Market Access and Government Affairs, Hollister launched a comprehensive campaign to address this long-standing issue. Through strategic policy engagement and unwavering dedication, the team worked closely with DME MACs to revise the coverage criteria. Their efforts paid off, resulting in a policy update that ensures equitable access to advanced care for one of the most vulnerable patient groups.
What’s Changing?
Starting January 1, 2026, any Medicare beneficiary diagnosed with a spinal cord injury at any level will automatically qualify for a closed system intermittent catheter. This update eliminates decades-old restrictions, opening the door to better health outcomes and improved quality of life for thousands.
Transforming Lives – Today and Tomorrow
For patients, this change means timely access to devices that promote independence and reduce infection risk. For healthcare professionals, it simplifies the prescribing process, allowing them to focus on delivering the best possible care. “This transformation is a significant step forward in Continence Care, giving clinicians and patients the freedom to choose the best product for their individual needs,” said Casey Haan.
Looking Ahead: Commitment to Innovation and Advocacy
This policy shift underscores Hollister’s ongoing commitment to patient advocacy and innovation. With a 100+ year history rooted in improving lives, the company continues to drive positive change in healthcare equity and compassionate care. As an independent, employee-owned organization with a global footprint, Hollister remains dedicated to its mission of making life more rewarding and dignified for those who use its products.
And this is the part most people miss: While this policy change is a huge step forward, it also raises questions about the broader healthcare system. Why do patients often have to fight for access to life-improving devices? And what other barriers still exist for vulnerable populations? Hollister’s success here is a call to action for the industry—a reminder that advocacy and innovation can break down even the most entrenched barriers. What do you think? Is this enough, or is there still work to be done? Share your thoughts in the comments below.**
About Hollister Incorporated
Hollister Incorporated is a global MedTech leader with a century-long legacy of innovation in Ostomy, Continence Care, and Critical Care solutions. With over 5,000 Associates across 24 countries, the company serves customers in nearly 80 nations, driven by its mission to enhance the lives of those who use its products. Learn more at https://www.hollister.com/ or follow @Hollister-Incorporated on LinkedIn.
